Trial Profile
A phase 1-2, multicenter, randomized, double-blind, placebo controlled, prospective study to evaluate the safety and potential efficacy of single, increasing doses of TG100-115 in subjects undergoing percutaneous coronary intervention for acute anterior ST elevation myocardial infarction
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 10 Oct 2005
Price :
$35
*
At a glance
- Drugs TG 100115 (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions
- 10 Oct 2005 New trial record.